N Liu, R Zhang, Q Shi, H Jiang,
Q Zhou - Bioorganic Chemistry, 2023 - Elsevier
The drugs targeting the PD-1/PD-L1 pathway have gained abundant clinical applications for
cancer immunotherapy. However, only a part of patients benefit from such immunotherapy …